Tangible Body Composition Changes: Measurable reductions in fat and/or increases in lean mass, typically after the 6-8 week mark
GHRP-6 stimulates GH release via activation of the ghrelin receptor, increasing appetite and enhancing the amplitude and frequency of GH pulses. Bowers et al., Endocrinology As a research peptide, GHRP-6 is not FDA-approved for clinical use, but it's commonly used in performance enhancement and hormone optimization circles for its regenerative, anti-catabolic, and appetite-boosting properties
Patients pursuing combination protocols typically pair Tesamorelin with a peptide that acts on a different pathway, such as Ipamorelin (which acts on the ghrelin receptor) or CJC-1295/Ipamorelin as a stack
While internal cellular support begins immediately, visible results like improved skin radiance usually take 8 to 12 weeks
GH and IGF-1 promote stronger bones